+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Antibody Drug Conjugate"

Cluster of Differentiation 3 (CD3) Antibody Market Report 2026 - Product Thumbnail Image

Cluster of Differentiation 3 (CD3) Antibody Market Report 2026

  • Report
  • February 2026
  • 250 Pages
  • Global
From
From
From
Monoclonal Antibody Therapeutics Market - Global Forecast 2026-2032 - Product Thumbnail Image

Monoclonal Antibody Therapeutics Market - Global Forecast 2026-2032

  • Report
  • September 2026
  • 182 Pages
  • Global
From
Bioanalytical Testing Services Market - Global Forecast 2026-2032 - Product Thumbnail Image

Bioanalytical Testing Services Market - Global Forecast 2026-2032

  • Report
  • September 2026
  • 186 Pages
  • Global
From
Protein Labeling Market - Global Forecast 2026-2032 - Product Thumbnail Image

Protein Labeling Market - Global Forecast 2026-2032

  • Report
  • September 2026
  • 180 Pages
  • Global
From
Bioconjugation Market - Global Forecast 2026-2032 - Product Thumbnail Image

Bioconjugation Market - Global Forecast 2026-2032

  • Report
  • September 2026
  • 193 Pages
  • Global
From
Antibody-Oligo Conjugation Kit Market - Global Forecast 2026-2032 - Product Thumbnail Image

Antibody-Oligo Conjugation Kit Market - Global Forecast 2026-2032

  • Report
  • September 2026
  • 186 Pages
  • Global
From
From
Humanized Monoclonal Antibody Market - Global Forecast 2026-2032 - Product Thumbnail Image

Humanized Monoclonal Antibody Market - Global Forecast 2026-2032

  • Report
  • September 2026
  • 181 Pages
  • Global
From
From
Flow Cytometry Antibody Products Market - Global Forecast 2026-2032 - Product Thumbnail Image

Flow Cytometry Antibody Products Market - Global Forecast 2026-2032

  • Report
  • September 2026
  • 188 Pages
  • Global
From
From
From
From
From
From
From
Loading Indicator

The Antibody Drug Conjugate (ADC) market is a subset of the biotechnology industry that focuses on the development of targeted therapies for cancer and other diseases. ADCs are composed of an antibody, a linker, and a cytotoxic drug. The antibody binds to a specific target on the surface of a cell, and the linker and drug are released when the ADC binds to the target. This allows for the delivery of a high dose of the drug to the target cell, while minimizing the damage to healthy cells. ADCs have been used to treat a variety of cancers, including breast, ovarian, and non-small cell lung cancer. They have also been used to treat other diseases, such as autoimmune disorders and infectious diseases. The ADC market is highly competitive, with many companies developing and marketing their own products. Some of the major players in the market include Seattle Genetics, ImmunoGen, Pfizer, Merck, and Novartis. Show Less Read more